Dermatology 2013

Notes: Morales-Cardona, Camilo A

Valbuena-Mesa, Martha C

Alvarado, Zulma

Solorzano-Amador, Andrea

eng

Germany

2013/11/28 06:00

Mycoses. 2014 May;57(5):284-93. doi: 10.1111/myc.12157. Epub 2013 Nov 27.

URL: http://www.ncbi.nlm.nih.gov/pubmed/24279435

Author Address: Centro Dermatologico Federico Lleras Acosta, National Institute of Dermatology of Colombia, Bogota D.C, Colombia.

 

 

Reference Type:  Journal Article

Record Number: 4302Author: Moreno-Ramirez, D., Ferrandiz, L., Ramirez-Soto, G. and Munoyerro, M. D.

Year: 2013

Title: [Quantitative analysis of drug expenditures variability in dermatology units]

Journal: Farm Hosp

Volume: 37

Issue: 5

Pages: 366-71

Date: Sep-Oct

Short Title: [Quantitative analysis of drug expenditures variability in dermatology units]

Alternate Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

ISSN: 0214-753X (Electronic)

1130-6343 (Linking)

DOI: 10.7399/FH.2013.37.5.636

Original Publication: Analisis cuantitativo de la variabilidad del gasto farmaceutico en unidades de Dermatologia.

Accession Number: 24128098

Keywords: Costs and Cost Analysis

Dermatologic Agents/economics

Dermatology/*economics

*Drug Costs/statistics & numerical data

Hospital Departments/*economics

Hospitals, Public/economics

Humans

National Health Programs/economics

Retrospective Studies

Skin Diseases/drug therapy/economics

Spain

Abstract: BACKGROUND: Variability in adjusted drug expenditures among clinical departments raises the possibility of difficult access to certain therapies at the time that avoidable expenditures may also exist. Nevertheless, drug expenditures are not usually applied to clinical practice variability analysis. AIMS: To identify and quantify variability in drug expenditures in comparable dermatology department of the Servicio Andaluz de Salud. METHODS: Comparative economic analysis regarding the drug expenditures adjusted to population and health care production in 18 dermatology departments of the Servicio Andaluz de Salud. The 2012 cost and production data (homogeneous production units -HPU-)were provided by Inforcoan, the cost accounting information system of the Servicio Andaluz de Salud. RESULTS: The observed drug expenditure ratio ranged from 0.97?/inh to 8.90?/inh and from 208.45?/HPU to 1,471.95?/ HPU. The Pearson correlation between drug expenditure and population was 0.25 and 0.35 for the correlation between expenditure and homogeneous production (p=0.32 and p=0,15, respectively), both Pearson coefficients confirming the lack of correlation and arelevant degree of variability in drug expenditures. CONCLUSION: The quantitative analysis of variability performed through Pearson correlation has confirmed the existence of drug expenditure variability among comparable dermatology departments.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295